Anastrozole shows greater carryover effects compared with tamoxifen and resolution of fracture risk post-treatment – data from ATAC at 100 months' median follow-up
R. SainsburvVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)70579-2
File:
PDF, 57 KB
english, 2008